Radar › Companies › Life Sciences · Veneto
Radar · Life Sciences in Veneto

Best Life Sciences Companies in Veneto, Italy

The 40 best Life Sciences companies in Veneto, Italy in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Arsenale BioYards.

40companies tracked
$18.4Mdisclosed funding
0unicorns
7have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × VENETO

Our analysis of 576 Life Sciences companies

$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

576companies analysed
70%cloud-native stacks
2025funding peak (by rounds)
13unicorns
2016median founding year

Ranked: Best Life Sciences companies in Veneto

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1Arsenale BioYards
Provider of platform for bio manufacturing with integrated hardware and software from lab to manufacturing
$10M18 mo agoSeedNiels Agerbaek
Co-Founder
2023Cart FunctionalitySquarespace CommerceSquarespace+18—1 award
2Sordina IORT Technologies
Developer of radiotherapy devices for cancer therapy
$3M50 mo agoFunding Raised—2013WordPress Block EditorElementorWordPress+2460 patents
Image-guided radiotherapy devices and control systems for precise cancer treatment
—
3Personal Genomics
Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals
$2M52 mo agoAcquiredJohnsee Lee
Founder & CEO
2011WordPressMySQLPHP+244 patents
Targeted nucleic acid detection and genomic region enrichment kit technologies
—
4D-EYE
Smartphone camera attachment for portable digital ophthalmoscopy or fundus imaging
$2M93 mo agoSeries ASpencer Lee
Founder
2014—5 patents
Optical accessories (lenses/filters) for mobile device cameras
—
5Diamante
Nanotechnology based tools for diagnostic kits
$996K43 mo agoSeedValentina Garonzi
CEO
2016—2 patents
Virus-derived nanoparticle delivery systems for therapeutic and agricultural applications
—
6CenterVue
Fundus imaging devices for ophthalmological diagnosis
$911K182 mo agoAcquiredGiuliano Barbaro
Co-Founder & CEO
2008—49 patents
Optical coherence tomography systems for retinal and ocular fundus imaging diagnostics.
—
7Microbion
Provider of services for food, agriculture, biotechnology and pharmaceutical industries
$271K48 mo agoFunding RaisedAntonio Del Casale
CEO & Co-Founder
2011—8 patents
Modular extragenic genetic markers for microbial strain differentiation and quantification
—
8BMR Genomics
Provider for DNA sequencing services
$199K106 mo agoFunding RaisedBarbara Simionati
CEO
2006———

Top 9 Life Sciences companies in Veneto

#1
Seed · Venice, Veneto · founded 2023
$10Mraised
▾

Provider of platform for bio manufacturing with integrated hardware and software from lab to manufacturing. It focused on building the industrial backbone of the bio economy, supporting the development of the biotechnology industry. It combines both hardware and software solutions, streamlining the process from laboratory research to scale manufacturing

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 10.4% of this cohort's audience
Activity: 1 awards announced in 12 mo
Funding rounds
  • Feb 2025Seed$10M
Founders & team
Niels AgerbaekCo-FounderArnaud LCo-FounderMassimo PortincasoCEO & Co-Founder
Investors
Planet A, Byfounders, Cassa depositi e prestiti Group, Acequia Capital, Plug and Play Tech Center, Grey Silo Ventures
Tech stack
AngularCart FunctionalityCloudflareCloudflare Bot ManagementCore-JsGoogle Analytics
#2
Acquired · Verona, Veneto · founded 2011
$1.9Mraised
▾

Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals. The company's consumer genomics services include personalized genome analysis for prediction of adverse drug response, clinical exome and whole-genome sequencing, Myocardial Infarction Risk assessment (MI Risk kit), high blood pressure, and cardiovascular disease risk assessment (Col Risk Kit) using genetic variants associated with the levels of LDL and HDL cholesterol and a non-invasive prenatal test (NIPT - Prenatal Insight).

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 11.8% of this cohort's audience
Funding rounds
  • May 2022Grant (prize money)$263.6K
  • Jan 2021Grant (prize money)$213.1K
  • Jun 2016Grant (prize money)$391K
  • Jan 2016Grant (prize money)$280.3K
Founders & team
Johnsee LeeFounder & CEO
Investors
Europa
Tech stack
Amazon Web ServicesApache Http ServerAws Certificate ManagerBootstrapCloudflareCloudflare Bot Management
#3
Funding Raised · Vicenza, Veneto · founded 2013
$2.6Mraised
▾

Developer of radiotherapy devices for cancer therapy. The company offer products such as the LIAC HWL, a technology designed to minimize scatter radiation in operating rooms, and the NOVAC 11, a solid technology used for IOeRT treatments. The company is also involved in research and development in the field of FLASH radiotherapy for cancer treatment.

Funding rounds
  • Jun 2022Grant (prize money)$2.6M
Investors
EIC Fund
Tech stack
Animate.CssBootstrapContact Form 7CookieyesCore-JsElementor
#4
Seed · Verona, Veneto · founded 2016
$996.5Kraised
▾

Diamante has innovated the development of diagnostic kits for the detection of autoimmune diseases. It uses plants as bioreactors for the development of nanomaterials that can display multiple antigens by modified plant viruses. These viruses are cloned for sequence codifying for the peptide of interests and the resultant vector is used for Nicotiana benthamiana infection. The leaves of the plant become symptomatic and are further processed for purification of viral nanoparticles.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 6.0% of this cohort's audience
Founders & team
Valentina GaronziCEO
Investors
Angels4Women, Angels4Impact, Arieli Group, Europa
#5
Series A · Padua, Veneto · founded 2014 · 5 employees
$1.6Mraised
▾

D-EYE has developed a portable retinal imaging system. The D-EYE Portable Eye and Retinal Imaging System attaches to a smartphone creating a portable ophthalmic camera or ophthalmoscope that records and transmits high definition images and videos for vision care screening and evaluation. D-Eye is capable of imaging the posterior chamber of the eye and can detect Glaucoma, Age-related Macular degeneration, Diabetic retinopathy, Optic neuritis, Blood vessel disorders thus making it useful for frontline retinal screening. The company also has a veterinary version of the product. D-EYE is Both FDA and CE registered. As of 2016, the company is developing the D-EYE’s ImageVault, an HIPAA-compliant “mobile-to-cloud” platform, to allow workflow management, sharing and archiving D-EYE videos, still images and corresponding data for instant access by ophthalmologists, optometrists, general practitioners and other medical specialists, facilitating widespread eye screening from anywhere. Also has an office in Pasadena, US. Additionally, develops cloud-based PaaS systems for telehealth apps and population data aggregation and analysis.

Funding rounds
  • Dec 2018Grant (prize money)$410.9K
  • Jan 2018Grant (prize money)$442.9K
  • Jan 2016Series A$1.6M
Founders & team
Spencer LeeFounder
Investors
CDP Venture Capital, Fondazione Cottino, Si14, Innogest Capital, Europa
#6
Funding Raised · Verona, Veneto · founded 2011 · 9 employees
$270.5Kraised
▾

Provider of services for food, agriculture, biotechnology, and pharmaceutical industries. The company is focused on providing R&D services in product development, microbiological strain characterization, safety, and toxicity assessment, and bio-banking. The company has expertise in genomic and metagenomic assessment and characterization of samples, strain-level species resolution, whole-genome mapping of newly identified organisms, authentication of microbial strains, detection of genes/variants associated with risks to human and/or animal health, analysis of antibiotic sensitivity, etc., and characterization of microbial communities in foods, beverages, environmental samples, and production setups.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 17.0% of this cohort's audience
Activity: 1 awards announced in 12 mo
Funding rounds
  • Sep 2022Grant (prize money)$270.5K
Founders & team
Antonio Del CasaleCEO & Co-FounderGiovanna FelisCo-FounderFabio FracchettiCo-Founder
Investors
Europa
Tech stack
WordpressMysqlPhpDebianWpbakeryContact Form 7
#7
Acquired · Padua, Veneto · founded 2008
$911Kraised
▾

CenterVue, a M31 alumnus, develops fundus imaging diagnostic devices for early detection of eye diseases such as Diabetic Retinopathy, Macular Degeneration and Glaucoma. Its products include the DRS whichis a traditional fundus camera, the Compass which is a Fundus Automated Perimeter that combines Visual Field measurement to TrueColor Confocal Imaging of the optic disc and RNFL, the Eidon is the a TrueColor Confocal Scanner that combines the advantages of SLO with the fidelity of true color fundus imaging, and the Maia device combines Images, Sensitivity and Fixation analysis for confocal microperimetry to assess macula integrity. Apart from these devices, Centervue also provides EKN which is an internet based software system, integrated with the DRS fundus camera and used to transmit retinal images and textual information, making them available for online consultation by authorized users, via the regular internet browser. CenterVue sells its products worldwide in more than 70 countries and a US subsidiary was started in 2010.

Funding rounds
  • 2011Seed$911K
Founders & team
Giuliano BarbaroCo-Founder & CEO
Investors
Sofimac Investment Managers
Tech stack
WordpressMysqlPhpWpmu Dev SmushYoast SeoWpml
#8
Funding Raised · Padua, Veneto · founded 2006
$199.4Kraised
▾

Provider for DNA sequencing services

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 7.9% of this cohort's audience
Funding rounds
  • Oct 2017Grant (prize money)$58.1K
  • May 2017Grant (prize money)$54.5K
  • Jan 2017Grant (prize money)$53K
  • Dec 2014Grant (prize money)$33.7K
Founders & team
Barbara SimionatiCEO
Investors
Europa, EIC Fund
#9
Late Stage · Sommacampagna, Veneto · founded 1981 · 200 employees
—raised
▾

Manufacturer and distributor of bone cement and biomaterials space intended to serve the orthopedic industry. The company develops bone cement, a product used for the fixation of orthopedic implants and for the filling of vertebral compression fractures and spacer technology, antibiotic-loaded temporary implants used to treat local infections that can occur in patients who have had implant surgery.

Founders & team
Denis FaccioliCEO
Investors
Keensight Capital, Astorg Partners
Tech stack
Apache Http ServerCdnjsCloudflareCloudflare Bot ManagementCookiebotGoogle Analytics

Funding & investor landscape

$18.4Mtotal disclosed funding
8companies funded
16disclosed rounds
0rounds last 90 days
Most active investors
Europa5 rounds
BizPlace2 rounds
EIC Fund2 rounds
Acequia Capital1 rounds
Angels4Impact1 rounds
Angels4Women1 rounds
Arieli Group1 rounds
Astorg Partners1 rounds
Byfounders1 rounds
CDP Venture Capital1 rounds

Notable founders

Niels Agerbaek
Co-Founder · Arsenale BioYards
Arnaud L
Co-Founder · Arsenale BioYards
Johnsee Lee
Founder & CEO · Personal Genomics
Valentina Garonzi
CEO · Diamante
Spencer Lee
Founder · D-EYE
Antonio Del Casale
CEO & Co-Founder · Microbion
Giovanna Felis
Co-Founder · Microbion
Giuliano Barbaro
Co-Founder & CEO · CenterVue
Barbara Simionati
CEO · BMR Genomics
Denis Faccioli
CEO · Tecres
Prism market signals · Italy · country-scoped Prism corpus, 1,494,526 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH SIGNALS · Italy

How research on Biotechnology is moving in Italy

A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,095 Italy-affiliated papers.

research sentiment over time
200820152026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and intensifying — the enthusiastic (strongly-positive) share moved 27% → 44% across 2008–2026.
top research entities
  • University of Milan77
  • University of Naples Federico II54
  • University of Padua51
  • University of Bologna49
  • University of Bari Aldo Moro48
leading researchers
Antonio Bevilacqua · Annalaura Lopez · Matteo Greco · F. Bellagamba · Carlos Camacho · Maria Rosaria Corbo · Carmen Scieuzo · Beatrice Marcolli
▲ Breakthroughs195 · 18%
▼ 27%→17% share
▼0.6× share momentum0 median citations79% since 2021mostly empirical
Breakthroughs are cooling (27%→17% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene3→16
  • Transcription (linguistics)1→7
  • DNA damage3→8
  • Mitochondrion1→5
  • Phosphorylation1→4
Newly emergingGene knockdown 0→7 · Messenger RNA 0→6 · Immune system 0→6
Landmark Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neuro · 9,015 cites
◆ Advancements458 · 42%
▲ 30%→44% share
▲1.5× share momentum0 median citations89% since 2021mostly empirical
Advancements are rising (30%→44% of field), led by Antimicrobial.
rising sub-themes (early→recent)
  • Antimicrobial1→15
  • Quality (philosophy)1→15
  • Antioxidant1→13
  • Crop2→14
  • Fermentation1→13
Newly emergingTranscriptome 0→15 · Nutraceutical 0→15 · Yield (engineering) 0→13
Landmark Biofertilizers function as key player in sustainable agriculture by improving soil fertility, plant tolerance and crop p · 1,137 cites
▼ Concerns217 · 20%
▼ 24%→19% share
▼0.8× share momentum0 median citations82% since 2021mostly reviews
Concerns are cooling (24%→19% of field), led by Agriculture.
rising sub-themes (early→recent)
  • Agriculture2→15
  • Antibiotic resistance1→14
  • Food safety2→12
  • Sustainability1→8
  • Livestock1→6
Newly emergingAntimicrobial 0→10 · Production (economics) 0→10 · Context (archaeology) 0→8
Landmark Natural products in drug discovery: advances and opportunities · 4,708 cites
RESEARCH HOTSPOTS · Italy

Where biotechnology is researched across Italy

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

Rome138 · +0.46
Hot · MycotoxinAdvancing · TranscriptomeOpportunity · Cell culture
Milan118 · +0.37
Hot · Gene expressionAdvancing · Abiotic stressOpportunity · In vitro
Naples76 · +0.44
Hot · NutrientAdvancing · ApoptosisOpportunity · Gene
Padua52 · +0.30
Hot · Selection (genetic algorithm)Advancing · Immune systemOpportunity · Fish Concern · Food safety
Bologna51 · +0.31
Hot · LivestockAdvancing · Abiotic componentOpportunity · Production (economics)Concern · Sustainability
Turin45 · +0.37
Hot · AgricultureAdvancing · GenomicsOpportunity · Phytochemical
Florence35 · +0.40
Hot · Yield (engineering)Advancing · In vitroOpportunity · Gene
Genoa24 · +0.48
Hot · GeneAdvancing · Immune systemOpportunity · Messenger RNA
Pisa22 · +0.30
Hot · CellOpportunity · Cell culture
Trieste12 · +0.33
Opportunity · Gene

Common questions

How many Life Sciences companies are there in Veneto, Italy?
Radar tracks 40 indexable Life Sciences companies headquartered in Veneto, Italy that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Veneto, Italy?
The Life Sciences companies in Veneto, Italy on this list have raised a combined $18.4M in disclosed equity funding across 8 funded companies.
Which is the highest-funded Life Sciences company in Veneto, Italy?
Arsenale BioYards is the highest-funded Life Sciences company in Veneto, Italy, with $10M in disclosed equity funding.
How many Life Sciences companies in Veneto, Italy are funded?
8 of the 40 Life Sciences companies in Veneto, Italy on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Veneto, Italy?
None of the Life Sciences companies in Veneto, Italy on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Veneto, Italy Life Sciences companies?
The most active investors in Veneto, Italy Life Sciences companies on this list include Europa, BizPlace, EIC Fund, Acequia Capital, Angels4Impact.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon